XORTX Therapeutics Inc. (XRTX) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 25.49K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 43.33K | 33.18K | 22.09K | 43K |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -25.49K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -43.33K | -33.18K | -22.09K | -43K |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | 100% | 100% | 100% | 100% | 52.07% | -13.45% | 23.28% | -245.3% |
| Operating Expenses | 786.4K | 686.42K | 716.2K | 889.95K | 963.46K | 661.26K | 874.75K | 1.49M | 1.09M | 983.67K | 1.49M | 1.76M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 753.75K | 495.11K | 392.94K | 465.83K | 477.8K | 407.03K | 546.63K | 817.91K | 695.9K | 684.5K | 712.23K | 1.05M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 32.65K | 54.86K | 57.01K | 186.75K | 276.31K | 7.76K | 34.74K | 92.61K | 99.75K | 182.69K | 764.13K | 667.91K |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 136.44K | 266.25K | 237.37K | 209.35K | 246.47K | 293.38K | 608.1K | 0 | 0 | 0 | 0 |
| Operating Income | -811.89K | -686.42K | -716.2K | -889.95K | -963.46K | -661.26K | 0 | -3.12M | -795.65K | -862.22K | -1.49M | -1.76M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 15.73% | -3.8% | - | 71.49% | -21.09% | 23.31% | 100% | -77.54% | 58.47% | -787.85% | 44.97% | 37.83% |
| EBITDA | -786.4K | -657.3K | -686.81K | -862.32K | -937.47K | -635.12K | -848.8K | -3.08M | -763.52K | -829.05K | -1.47M | -1.73M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 16.11% | -3.49% | 19.08% | 71.97% | -22.78% | 23.39% | 42.24% | -78.21% | 58.7% | -636.27% | 45.14% | 38.75% |
| D&A (Non-Cash Add-back) | 25.49K | 29.11K | 29.39K | 27.63K | 25.98K | 26.14K | 25.95K | 45.22K | 32.13K | 33.18K | 16.47K | 32.02K |
| EBIT | -811.89K | -686.42K | -716.2K | -889.95K | -963.46K | -661.26K | -874.75K | -1.49M | -1.09M | -983.67K | -1.39M | -1.76M |
| Net Interest Income | 1.61K | 3.92K | 7.2K | 12.33K | 18.42K | 25.33K | 29.02K | 35.95K | 31.6K | 49.81K | 63.61K | 73.31K |
| Interest Income | 1.61K | 3.92K | 7.2K | 12.33K | 18.42K | 70.43K | 29.02K | 35.95K | 31.6K | 49.81K | 63.61K | 73.31K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 14.62K | 95.95K | 66.73K | 172.25K | 264.78K | 783.8K | -587.01K | 3.29M | -2.22M | 3.56M | 152.67K | 66.32K |
| Pretax Income | -797.27K | -590.46K | -649.47K | -717.7K | -698.67K | 122.53K | -587.01K | 170.07K | -3.02M | 2.7M | -1.33M | -1.69M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.05M | 0 | 455.02K | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -34.86% | 0% | -34.13% | 0% |
| Net Income | -797.27K | -590.46K | -649.47K | -717.7K | -698.67K | 122.53K | -587.01K | 170.07K | -3.02M | 2.7M | -1.33M | -1.69M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -14.11% | -581.87% | -10.64% | -522.01% | 76.86% | -95.46% | 55.98% | 110.05% | -64.79% | 192.5% | -11.38% | -36.57% |
| Net Income (Continuing) | -797.27K | -590.46K | -649.47K | -717.7K | -698.67K | 122.53K | -587.01K | 170.07K | -4.07M | 2.7M | -1.79M | -1.69M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.57 | -2.37 | -3.25 | -4.75 | -4.75 | 0.93 | -5.00 | 1.75 | -31.00 | 30.50 | -16.75 | -21.25 |
| EPS Growth % | 88% | -356.22% | 35% | -371.43% | 84.68% | -96.97% | 70.15% | 108.24% | -77.14% | 167.78% | 19.28% | 22.73% |
| EPS (Basic) | -0.57 | -2.37 | -3.25 | -4.75 | -4.75 | 0.93 | -5.00 | 1.75 | -31.00 | 30.50 | -16.75 | -21.25 |
| Diluted Shares Outstanding | 1.39M | 262.43K | 194.26K | 151.53K | 149.49K | 132.31K | 116.14K | 116.14K | 97.17K | 79.95K | 79.96K | 79.95K |
| Basic Shares Outstanding | 1.39M | 262.43K | 194.26K | 151.53K | 149.49K | 132.31K | 116.14K | 116.14K | 97.17K | 79.95K | 79.95K | 79.95K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |